Bioreactors Market Projections 2027 | Merck Group, Cytiva, Getinge, Eppendorf AG, Sartorius Group and Thermo Fisher Scientific

The bioreactors market is expected to expand on the back of rising requirement for improved pharmaceuticals, vaccines, and antibodies worldwide. The COVID-19 pandemic has impacted millions of lives across the globe. Surge in casualties caused by the pandemic has sparked an increase in demand for vaccines and other biologics to control the spread of the virus.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/141

To meet the global demand for COVID-19 vaccines, biopharmaceutical companies are spearheading research and development (R&D) activities, generating record demand for bioreactors. Recently, the Serum Institute of India was said to incorporate six 4,000L CSR bioreactors for mass producing Novavax’s COVID-19 vaccine candidate. With this, the pharma giant’s facility would have the largest single-use bioreactor-based production line in the globe.

Growing R&D expenditure by governments in the healthcare domain could also offer a considerable boost to businesses manufacturing bioreactors. According to a report published by Global Market Insights, the bioreactors market share was esteemed at over USD 5.4 billion in the year 2020 and is projected to witness a 16.6% CAGR by 2027.

Major players operating in the global bioreactors industry include Sartorius Stedim Biotech Group, Cytiva, Eppendorf, and Merck Group among other players. Strategic initiatives like mergers, acquisitions, and new product launches, are some of the approaches taken by bioreactor manufacturers to hold and maintain their position in the market. Highlighting an instance, in January 2020, Getinge completed the acquisition of Applikon Biotechnology B.V., a company involved in manufacturing and supply of advanced bioreactors for R&D in biopharmaceutical companies. The strategy was slated to strengthen the firm’s life sciences business with portfolio expansion.

The demand for cancer therapeutic drugs is rising exponentially. Growing cases of cancer has influenced the development of bioprocessing equipment, adoption of advanced technologies, and increasing demand for single-use bioreactors for developing effective cancer treatments. Rising investments in research and development programs by governments and major players may augment the revenue strides of bioreactors market.

Request for customization @ https://www.gminsights.com/roc/141

The Asia Pacific region is expected to witness lucrative demand for bioreactors in the estimated timeframe. Presence of firms with robust manufacturing capacity in the healthcare sector and advancements in hi-tech technology may support promising developments in the bioreactors market. As per a report, the Asia Pacific constituted to around 20% of the global bioreactors market share in 2020. The region offers multiple opportunities to national and international pharmaceutical companies for collaborations, innovative and product development with the government initiatives and investments in healthcare and R&D offering needed support.

Partial Chapter of the Table of Content

Chapter 4 Bioreactors Market, By Product Type

4.1 Key segment trends

4.2 Single-use

4.2.1 Market size, by region, 2016-2027 (USD Million)

4.3 Reusable

4.3.1 Market size, by region, 2016-2027 (USD Million)

Chapter 5 Bioreactors Market, By Cell

5.1 Key segment trends

5.2 Mammalian cells

5.2.1 Market size, by region, 2016-2027 (USD Million)

5.3 Bacterial cells

5.3.1 Market size, by region, 2016-2027 (USD Million)

5.4 Yeast cells

5.4.1 Market size, by region, 2016-2027 (USD Million)

5.5 Others

5.5.1 Market size, by region, 2016-2027 (USD Million)

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/bioreactor-market

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

This release was published on openPR.